APA (7th ed.) Citation

Z, Z., B, C., J, Y., J, Z., Y, Z., M, S., . . . X, W. (2022). Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study. Frontiers in oncology, 12, 901061. https://doi.org/10.3389/fonc.2022.901061

Chicago Style (17th ed.) Citation

Z, Zhan, Chen B, Yu J, Zheng J, Zeng Y, Sun M, Peng L, Guo Z, and Wang X. "Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study." Frontiers in Oncology 12 (2022): 901061. https://doi.org/10.3389/fonc.2022.901061.

MLA (9th ed.) Citation

Z, Zhan, et al. "Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study." Frontiers in Oncology, vol. 12, 2022, p. 901061, https://doi.org/10.3389/fonc.2022.901061.